Here's another article on the injectable form of Cabotegravir. The claim is the same, an injection taken every 2 months that surpasses the benefits of daily Truvada for PrEP. Yay! right? Maybe not.
The problem's the same. The research has only been conducted on men & those born male. At least that's the data presented. For a while, they've claimed research on how the med behaves with women was ongoing. So far, nothing.
If a med doesn't treat half the population affected by an issue, it's hardly a game changer. As usual women were left out of a medical study, because the outcomes were different or difficult. Medical research has to get better or HIV is never going away.
Cya...
No comments:
Post a Comment